Evaluation of Reference variability [Design Issues]

posted by Nirali – India, 2009-04-17 09:38 (6284 d 15:26 ago) – Posting: # 3551
Views: 5,776

Thank you friends.

Actually, we got the proposal to evaluate reference variability using below design:
"2-period replicate design to assess the intra-subject variability of reference drug, in which reference drug given in both the periods".

Shall it be appropriate design to evaluate reference variability for EU regulatory? :confused:

Regards,
NIRALI

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
246 visitors (0 registered, 246 guests [including 39 identified bots]).
Forum time: 01:05 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5